Literature DB >> 17111385

The apoptosis of blood polymorphonuclear leukocytes in sickle cell disease.

Hakan Ozdogu1, Can Boga, Oktay Sozer, Nurzen Sezgin, Ebru Kizilkilic, Erkan Maytalman, Defne Yalcintas.   

Abstract

BACKGROUND: The apoptosis of human polymorphonuclear leukocytes (PMNs) in patients with sickle cell disease (SCD) is not well understood. The goal of this study was to examine the apoptosis of PMNs in patients with SCD and in controls.
METHODS: Flow cytometric quantitation of PMN apoptosis was performed in 17 patients during and after sickle cell vasoocclusive crisis and in 17 healthy volunteers. Plasma nitric oxide concentrations were also measured in patients with SCD.
RESULTS: The mean of annexin-V and annexin-V/PI staining (early and late apoptotic cells) increased to a greater degree in patients with SCD than in healthy controls for patients with SCD during and after vasoocclusive crisis. The mean of PI staining showing dead cells was higher only in patients after SCD crisis than in healthy controls. In the SCD groups during and after vasoocclusive crisis, there was no difference between PMN apoptosis levels. Furthermore, plasma nitric oxide concentrations were not correlated with PMN apoptosis.
CONCLUSIONS: There was an evidence that the alteration of blood PMN apoptosis could contribute to the pathogenetic mechanisms of vasoocclusion in patients with SCD. This can be attributed to the effects of numerous inflammatory mediators rather than simply the effects of nitric oxide. Copyright 2007 Clinical Cytometry Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17111385     DOI: 10.1002/cyto.b.20160

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  2 in total

1.  Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.

Authors:  Anthony O Awojoodu; Philip M Keegan; Alicia R Lane; Yuying Zhang; Kevin R Lynch; Manu O Platt; Edward A Botchwey
Journal:  Blood       Date:  2014-07-29       Impact factor: 22.113

2.  A common molecular signature of patients with sickle cell disease revealed by microarray meta-analysis and a genome-wide association study.

Authors:  Cherif Ben Hamda; Raphael Sangeda; Liberata Mwita; Ayton Meintjes; Siana Nkya; Sumir Panji; Nicola Mulder; Lamia Guizani-Tabbane; Alia Benkahla; Julie Makani; Kais Ghedira
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.